San Diego, CA, United States of America

Tara Nekoroski

This inventor holds 6 USPTO granted patents and 4 published patent applications. Top assignee: Halozyme, Inc.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tara Nekoroski. Retrieved from https://idiyas.com/inventor/tara-nekoroski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 100.0

Average Co-Inventor Count = 6.9

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Tara Nekoroski and Her Breakthrough in Hyaluronidase Enzyme Formulations

Introduction:

Tara Nekoroski, an innovative inventor based in San Diego, California, has made significant contributions to the field of biochemistry with her patent in hyaluronidase enzyme formulations. Her work focuses on enhancing the delivery of therapeutic agents, providing promising solutions for various medical treatments.

Latest Patents:

Nekoroski holds a patent titled "Hyaluronidase enzyme formulations for high volume administration." This patent outlines a formulation that combines hyaluronidase enzyme with a therapeutically effective amount of an active ingredient. It further details a method for administering a high volume of the formulation in a single instance, aiming to effectively treat diseases or disorders in patients.

Career Highlights:

Tara is currently employed at Halozyme, Inc., a biotechnology company known for its innovative therapeutic products and drug delivery technologies. Her role at Halozyme allows her to work at the forefront of medical science, contributing to advances that have the potential to improve patient outcomes significantly.

Collaborations:

Throughout her career, Tara has collaborated with esteemed coworkers, including David W Kang and Robert James Connor. Together, they have aimed to push the boundaries of knowledge and innovation in enzyme formulations and their applications in medicine.

Conclusion:

Tara Nekoroski's pioneering work in hyaluronidase enzyme formulations illustrates her commitment to advancing medical science and enhancing the effectiveness of treatment protocols. As she continues her journey at Halozyme, those in the field eagerly anticipate the future innovations that she will bring to light.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…